Jan-Erik Ingenhoff

Title: Jan-Erik Ingenhoff: Innovator in Pharmaceutical Synthesis

Introduction

Jan-Erik Ingenhoff is a notable inventor based in Horgen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. His work focuses on developing new methods that enhance the efficacy and safety of pharmaceutical products.

Latest Patents

Ingenhoff holds a patent for a synthetic path to pharmaceutically acceptable Vismodegib. This invention relates to a new route of synthesis to obtain Vismodegib, which is crucial for treating basal-cell carcinomas. The patent also includes suitable pharmaceutical compositions and outlines the use of the compound in medical treatments.

Career Highlights

Throughout his career, Ingenhoff has demonstrated a commitment to advancing pharmaceutical science. His innovative approaches have led to the development of effective treatments that benefit patients suffering from specific types of cancer. His work is recognized for its potential impact on the pharmaceutical industry.

Collaborations

Ingenhoff has collaborated with notable professionals in the field, including Christian Manfred Frech and Pasquale Gabriele Grieco. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion

Jan-Erik Ingenhoff is a distinguished inventor whose work in pharmaceutical synthesis is paving the way for new treatments. His contributions are vital to the ongoing advancements in medicine, particularly in oncology.